No. This is two studies. One with 500 patients and another with 350 patients. It is entirely appropriate to “break the study” when the implications are enormous. It’s over boys. If these things are true, it’s over. We have umpteen regional hot spots, each progressing at their own pace. Our mitigation efforts haven’t kicked in so we won’t see a big drop in deaths for a week but now we can have confidence it is coming. We have done what no other country on earth could do. It’s like avoiding a large scale thermonuclear attack and Trump deserves every bit of the credit.
I don’t know that I would buy stock in Quinilones, though. When we need a drug for this you can bet there will be a bettter one. It’s a terrible drug.